"Adventist Health White Memorial is a 353-bed, nonprofit, faith-based teaching hospital, providing a full range of inpatient, outpatient, emergency and diagnostic services to communities in and near downtown Los Angeles. Keeping our communities healthy has been our mission ever since our hospital was founded by the Seventh-day Adventist Church in 1913. Today, Adventist Health White Memorial is one of the region's leading nonprofit hospitals. Services include cardiac and vascular care, intensive and general medical care, oncology, orthopedic care, rehabilitation, specialized and general surgery, and women's and children's services."

During the past decade, White Memorial Medical Center conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "White Memorial Medical Center" #1 sponsor was "Pfizer" with 2 trials, followed by "Clovis Oncology, Inc." with 1 trials sponsored, "Diamyd Inc" with 1 trials sponsored, "ImmunityBio, Inc." with 1 trials sponsored and "Seagen Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "White Memorial Medical Center" #1 collaborator was "Merck Sharp & Dohme LLC" with 1 trials as a collaborator, "Paragon Biomedical" with 1 trials as a collaborator and "invivodata, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "White Memorial Medical Center" are "Respiratory Tract Infection" (2 trials), "Esophageal Squamous Cell Carcinoma" (1 trials), "Gastric Adenocarcinoma" (1 trials), "Gastroesophageal Junction Adenocarcinoma" (1 trials) and "Head and Neck Squamous Cell Carcinoma" (1 trials). Many other conditions were trialed in "White Memorial Medical Center" in a lesser frequency.

Most popular intervention types in "White Memorial Medical Center" are "Biological" (3 trials) and "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "CO-1.01" (1 trials), "Carboplatin + Nab-paclitaxel or Paclitaxel + Pembrolizumab" (1 trials), "Cisplatin or Carboplatin + Pembrolizumab + Pemetrexed" (1 trials) and "Gemcitabine" (1 trials). Other intervention names were less common.

The vast majority of trials in "White Memorial Medical Center" are 4 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "White Memorial Medical Center". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in White Memorial Medical Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in White Memorial Medical Center, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".